BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11002395)

  • 1. Erectile function and quality of life after interstitial radiation therapy for prostate cancer.
    Sánchez-Ortiz RF; Broderick GA; Rovner ES; Wein AJ; Whittington R; Malkowicz SB
    Int J Impot Res; 2000 Sep; 12 Suppl 3():S18-24. PubMed ID: 11002395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency preservation following stereotactic body radiation therapy for prostate cancer.
    Obayomi-Davies O; Chen LN; Bhagat A; Wright HC; Uhm S; Kim JS; Yung TM; Lei S; Batipps GP; Pahira J; McGeagh KG; Collins BT; Kowalczyk K; Bandi G; Kumar D; Suy S; Dritschilo A; Lynch JH; Collins SP
    Radiat Oncol; 2013 Nov; 8():256. PubMed ID: 24180317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile function after prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M; Kikuchi E; Maeda T; Nakashima J; Sugawara A; Ando T; Mizuno R; Nagata H; Miyajima A; Shigematsu N; Oya M
    J Urol; 2013 Mar; 189(3):1014-8. PubMed ID: 23017516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM; Stock RG; Buckstein M; Stone NN
    BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
    Gay HA; Sanda MG; Liu J; Wu N; Hamstra DA; Wei JT; Dunn RL; Klein EA; Sandler HM; Saigal CS; Litwin MS; Kuban DA; Hembroff L; Regan MM; Chang P; ; Michalski JM
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):304-317. PubMed ID: 28463150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
    Stock RG; Stone NN; Iannuzzi C
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):267-72. PubMed ID: 8635932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of erectile function following treatment for prostate cancer.
    Alemozaffar M; Regan MM; Cooperberg MR; Wei JT; Michalski JM; Sandler HM; Hembroff L; Sadetsky N; Saigal CS; Litwin MS; Klein E; Kibel AS; Hamstra DA; Pisters LL; Kuban DA; Kaplan ID; Wood DP; Ciezki J; Dunn RL; Carroll PR; Sanda MG
    JAMA; 2011 Sep; 306(11):1205-14. PubMed ID: 21934053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
    Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age on quality of life in patients with localized prostate cancer treated with high-dose rate brachytherapy combined with external beam radiotherapy.
    Kikkawa K; Iba A; Kohjimoto Y; Noda Y; Sonomura T; Hara I
    Int J Urol; 2018 Apr; 25(4):366-371. PubMed ID: 29397569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
    Whaley JT; Levy LB; Swanson DA; Pugh TJ; Kudchadker RJ; Bruno TL; Frank SJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e765-71. PubMed ID: 22300559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
    Pugh TJ; Mahmood U; Swanson DA; Munsell MF; Wang R; Kudchadker RJ; Bruno TL; Frank SJ
    Brachytherapy; 2015; 14(2):160-5. PubMed ID: 25255712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy.
    Valicenti RK; Bissonette EA; Chen C; Theodorescu D
    J Urol; 2002 Dec; 168(6):2499-504; discussion 2504. PubMed ID: 12441949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile function durability following permanent prostate brachytherapy.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile function after stereotactic body radiotherapy for localized prostate cancer.
    Dess RT; Hartman HE; Aghdam N; Jackson WC; Soni PD; Abugharib AE; Suy S; Desai NB; Zumsteg ZS; Mehra R; Morgan TM; Feng FY; Hamstra DA; Schipper MJ; Collins SP; Spratt DE
    BJU Int; 2018 Jan; 121(1):61-68. PubMed ID: 28710895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?
    Chen CT; Valicenti RK; Lu J; Derose T; Dicker AP; Strup SE; Mulholland SG; Hirsch IH; McGinnis DE; Gomella LG
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):591-5. PubMed ID: 11395224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year potency preservation after iodine-125 prostate brachytherapy.
    Nishimura S; Yorozu A; Ohashi T; Sakayori M; Yagi Y; Nishiyama T; Saito S; Shiraishi Y; Yoshida K; Toya K; Shigematsu N
    Int J Clin Oncol; 2014 Oct; 19(5):940-5. PubMed ID: 24170247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.